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Background: Postoperative adhesions remain a signiﬁcant complication of abdominal surgery and can
result in pain, infertility and potentially lethal bowel obstruction. Pharmacotherapy and barrier devices
have reduced adhesion formation to varying degrees in preclinical studies or clinical trials.
Materials and methods: In this study, we produced blends between chitosan (Ch) and gelatin (G) with
various compositions (Ch/G 100/0, 75/25, 50/50, 25/75 w/w) as candidate materials for prevention of
postoperative abdominal adhesion. For in vivo analysis, 30 female rats weighing 200e250 g were divided
into 5 groups (One control and 4 treatment groups). Under general anesthesia, the anterior surface of
serous membrane in rat was scraped slightly with sterile gauze until obvious congestion and small
bleeding drops appeared, then sample ﬁlms set on the cecum in treatment groups and the intestine was
put back into the abdominal cavity, which were then closed. After 4 weeks, the abdominal cavity was
reopened and the grades of peritoneal adhesion were studied by macroscopic and pathologic
assessments.
Results: Our results showed Ch1/G3 ﬁlms had an insigniﬁcant reduction effect on postoperative adhe-
sion, but surprisingly, the sample with more than 25% by weight of chitosan did not have any effect on
reducing adhesion formation but also increased inﬂammation near the cecum.
Conclusion: Administration of chitosanegelatin ﬁlms with higher than 25% weight of chitosan had no
effect on reduction of adhesion formation in the rat cecum model.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Adhesions are described as abnormal ﬁbrous connections that
develop between tissues and organs as a result of inﬂammatory
processes, such as infections and inﬂammation, endometriosis, but
most frequently as a sequel to surgical trauma following incision,
cauterization, suturing, or other tissue trauma. Adhesions develop
after nearly all open abdominal surgical procedures.1 The relevance
of adhesions to gynecology not only relates to infertility and
abdominal pain, but also to the occurrence of bowel obstruction.2
Adhesions complicate future surgery with important associated
morbidity, expense and a considerable risk of mortality. Despite
advances in surgical techniques in recent years, the burden of
adhesion-related complications has not changed.3e).
ciates Ltd. Published by Elsevier LtPharmacotherapy and barrier devices have reduced adhesion
formation to varying degrees in preclinical studies or clinical trials;
however, complete prevention of adhesions remains to be accom-
plished. The barrier systems include polymer solutions pre-formed
or in situ cross-linkable hydrogels and preformed solid sheets
designed to cover affected organs and reduce contact between
adjacent organs.4 The physical separation of traumatized serosa
areas using barriers represents the most important clinical strategy
for adhesion prevention. However, the optimal material has not yet
been found.5
An ideal barrier system should be easy to use via both lapa-
roscopy and open procedures providing unrestricted coverage of
the affected peritoneum, and remain effective throughout the
healing.4 Some preformed solid sheet such carboxymethyl cellulose
(CMC),6 oxidized regenerated cellulose (ORC), Expanded poly-
tetraﬂuoroethylene (ePTFE), and polyethyleneglycol have been re-
ported as antiadhesive agents in experimental models.7 In addition,d. All rights reserved.
Table 1
Composition of ﬁlms.
Films Chitosan (g) Gelatin (g) wtCh/wtG
Ch 0.5 0 100/0
Ch3/G1 0.5 0.165 75/25
Ch1/G1 0.5 0.5 50/50
Ch1/G3 0.5 1.5 25/75
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acid,4 dextran-based injectable hydrogel,8 PEGePCLePEG9 and
PCLAePEGePCLA hydrogels10 have been studied.
As another solution, controlled release technology could provide
sustained drug levels, and if desirable, could also provide a barrier
function.11 In our past publication, some pharmaceutics were
investigated,12 in current research; some polymeric ﬁlms are
evaluated as postoperative adhesion barriers.
Chitin is a co-polymer of N-acetyl-glucosamine and N-glucos-
amine units randomly or block distributed throughout the
biopolymer chains13 and Chitosan is produced industrially by
alkaline hydrolysis of chitin.14 Chitosan is currently receiving a
great deal of interest for medical and pharmaceutical applications.
The main reason of this increasing attention is certainly its inter-
esting intrinsic properties.15 In addition, chitosan is known as a
biocompatible material allowing its use in various medical appli-
cations such as implantation.13 Moreover, chitosan is metabolized
by certain human enzymes, especially lysozyme and is considered
as biodegradable.16 Biodegradability and biocompatibility, together
with speciﬁc interactions with components of the extracellular
matrix and growth factors, have led to growing use of chitosan in
tissue engineering, such as in the repair of skin, bone, and carti-
lage.17,18 Besides, in medical and pharmaceutical applications, chi-
tosan is participated as a component in hydrogels. Recently a new
derivative of chitosane hydroxybutyl chitosan (HBC) introduced as
a thermosensitive chitosan-based hydrogel barrier for post-
operative adhesion prevention.19
On the other hand, gelatin is obtained by thermal denaturation
or physical and chemical degradation of collagen. As a biomate-
rial, gelatin displays several advantages: it is a natural polymer,
which has not shown antigenity, it is completely resorbable
in vivo and its physicochemical properties can be suitably
modulated.20
Some studies reported excellent ability of chitosanegelatin
network to be used in human skin ﬁbroblast, keratinocyte trans-
plantation and skin regeneration.21 Also many studies are devel-
oped about using chitosanegelatin scaffolds in tissue
engineering.22,23 When gelatin and chitosan are blended together,
the structure formed can affect the spatial distribution of integrin
ligands and polycationic chitosan interaction with the anionic cell
surface. These effects inﬂuence cell adhesion, cellular bioactivity,
tissue remodeling process and ultimately the quality of the re-
generated tissue. It seems, this combination can have effect in
adhesion prevention with the same reason, something that other
researchers reported before.24
In this study, as part of our ongoing effort to develop a biode-
gradable ﬁlm as anti adhesion barrier, chitosanegelatin ﬁlm has
been chosen as a novel candidate material. For this, we created a
series of chitosanegelatin composite ﬁlms by varying the ratio of
components. The purpose of this work was to prepare soft and
elastic biomaterial that can be used as a barrier. Because of the
desirable biological activity of chitosan and gelatin, a combination
of these two biopolymers may also have beneﬁcial effects on the
biological characteristics of composite ﬁlms. The major advantages
of this combination are its simplicity, low cost and the potentially
improved mechanical properties.
2. Material and methods
2.1. Materials
Chitosan, low molecular weight (448,869, DDA ¼ 75% e 85%)
and type A porcine skin gelatin (G8150) were obtained from Sigma
Aldrich Chemical Co. All other reagents were local products of
analytical grade.2.2. Film preparation
Films were prepared according to the methods of Zhang with
minor modiﬁcations.25 For this goal, 0.5 g of chitosanwas dissolved
in 50 ml of 1% acetic acid solution. Then a weight amount of gelatin
was poured into chitosan solution and the mixture was stirred for
2 h at 50 C. The resultant solution was centrifugally degassed for
10 min to prevent air bubbles from forming. The mixture was cast
into plastic Petri dishes with 75 mm diameter, dried at 25 C for
24 h and washed with 100% ethanol until the ﬁlms became neutral
(pH ¼ 7). The ﬁlms were then dried and cut to patches of
5 cm  5 cm in size and 60 mm in thickness. The contents of
components are presented in Table 1.
2.3. Animals
After obtaining the approval of the Institutional Review Board of
our medical school, all experiments were carried out in accordance
with the Guidelines of the Animal Care and use ethics committee of
Baqiyatallah University of medical sciences.
Thirty female adult Wistar rats weighting 230  20 g were
maintained under standard laboratory conditions. Animals were
housed in an environment of 210.5 C with a relative humidity of
50  10% and a 12-h lightedark cycle. Food and water were always
available. Rats were randomly divided into ﬁve groups (n ¼ 6)
include: one control and four treatment groups (Chitosan, Ch3/G1,
Ch1/G1, Ch1/G3).
2.4. Surgical procedure
Surgical procedure was done according to our previous
study.12 Brieﬂy, rats were anesthetized with 90 mg/kg ketamine
hydrochloride and 8 mg/kg xylazine hydrochloride intramuscu-
larly. Following a 3 cm midline incision, antimesenteric border of
cecum was abraded with dry sterile gauze until punctuate
bleeding occurred. In treatment groups after rubbing 5 times
(typically provided punctuate bleeding), ﬁlms set on cecum
surface without using any adhesive material or suture. In control
group, no medication was administered, only cecum was exposed
to air for 5 min. After administration part, abdominal wall and
skin of animals were closed, using 4-0 polypropylene (PROLENE,
Ethicon, Edinburgh, UK) continuous sutures, respectively. The
duration from opening to closing the abdominal cavity was
5 min, so that the duration of exposure of intestines to air was
the same for each rat. The rats resumed their preoperative
routine until the 28th postoperative day, when they were killed
by an overdose of ether.
2.5. Macroscopic assessments
On reoperation day, the abdominal cavity was inspected
through a straight incision and adhesions were identiﬁed, counted,
and graded using the macroscopic and pathological assessment
that was described in our previous study.12 Therefore, macroscopic
assessment carried out by following grading method; Grade 0: No
adhesion, grade 1: The ratio of adhesive area/total treated area is
Table 2
Macroscopic adhesion grade in groups. Ch1/G3 has lower scores in adhesion grade,
however differences between all groups is insigniﬁcant (P > 0.05).
Adhesion score Control Ch Ch3/G1 Ch1/G1 Ch1/G3
Grade 0 e e 1 1 2
Grade 1 3 3 e 1 1
Grade 2 1 e 3 1 2
Grade 3 1 2 2 2 1




1.6  0.4 2.17  0.54 2  0.45 1.8  0.59 1.33  0.5
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is  50% and the adhesion is easily to be dissected, grade 3: Area of
the adhesion is out of consideration and it is difﬁcult and the in-
testinal wall will be impaired after the blunt dissection, grade 4:
The adhesion is fast and cannot be bluntly dissected, also may have
adhesion to other organs (liver).
2.6. Pathologic and quantitative assessments
For morphologic and pathologic assessment, tissues recovered
from the necropsy were ﬁxed in 10% formalin, embedded in
parafﬁn, sectioned, and stained with hematoxylin and eosin with
using standard techniques. Quantitative analysis includes area of
ﬁbrous tissue around cecum and numbers of ﬁbroblast cells were
done. In addition, histomorphological ﬁndings were assessed with
respect to the severity of interstitial ﬁbrosis (IF) and inﬂammatory
cell reaction (ICR). The extent of ICR was graded on a scale as fol-
lows: (0) for normal; (1) for mild; (2) for moderate and (3) for se-
vere. The intensity of ﬁbrosis was examined in 10 randomly
selected high power ﬁelds (HPF) .The amount of ﬁbrosis was also
scored as follows: (0) no ﬁbrosis; (1) minimal, loose ﬁbrosis; (2)
moderate ﬁbrosis and (3) ﬂorid dense ﬁbrosis. For evaluating
ﬁbroblast cells in adhesion area, 10 randomly selected high power
ﬁelds (HPF) pictures with 400 zoom of adhesion bond in every
samples were taken and average of ﬁbroblast cell numbers were
then calculated.
2.7. Statistical analyses
A comparison of the groups was carried out using the non-
parametric KruskaleWallis test followed by ManneWhitney U
statistics, to detect the statistically signiﬁcant differences among
the groups. Data were presented as mean  SEM. Analysis was




Most animals survived in the experiment and reached the
endpoint of observation in an apparently healthy condition except
for one animal from control group and another one from Ch1/
G1group (died on the 3rd and 8th postoperative day). On macro-
scopic observation, adhesion formation was not observed around
cecum in some animals after 4 weeks, however adhesion bonds
with pieces of residual ﬁlms with ﬁbrous tissue are observed
around the cecum in some rats of treatment groups (Fig. 1).Fig. 1. Macroscopic view of cecum. A) Animal in group Ch1/G3, cecumwith no adhesion bon
be seen.Macroscopic adhesion assessments of all groups are shown in
Table 2. However, mean of adhesion scores in Ch1/G3 group
(1.33  0.5) was lower than other groups, but differences were not
signiﬁcant (P > 0.05).
3.2. Quantitative analysis
In this study, we created new methods for reporting some
quantitative elements related to adhesion bond around cecum.
Results of these calculations can be seen in Fig. 2A. Samples in Ch1/
G3 group have lowest ﬁbroblast cells number compare to other
treatment groups (P < 0.05) but compare to control group differ-
ence was insigniﬁcant (P ¼ 0.17). As another quantitative analysis,
after preparing scanning picture from laboratory slides of samples,
ﬁbrous area around one cm length of cecum was evaluated with
using “Motic-Images 2000, release 1.2” software. Experiments were
run in triplicate per sample. All data were expressed as
means  SEM for n ¼ 3. Results of this assessment are shown in
Fig. 2B. Samples withmore contents of Chitosan have higher ﬁbrous
area around cecum and Ch1/G3 group has lowest adhesion area
compare to other groups but compare to control group difference
was insigniﬁcant (P > 0.05).
3.3. Pathological assessment
Histopathologic ﬁndings of adhesion area in all groups are
shown in Table 3. Ch1/G3 group had lowest ﬁbrosis and inﬂam-
mation score between all groups but difference was insigniﬁcant
(P > 0.05). It seems, increasing chitosan not only had no effect on
reduction of inﬂammation and ﬁbrosis near cecum but also induce
more inﬂammatory reactions. In addition, histopathological photos
of samples showed presence of residual pieces of ﬁlms in all
treatment groups except Ch1/G3 (Fig. 3). Intestinal epithelium is
shown in Fig. 3A. Mild adhesion bond around the cecum in control
group can be seen in Fig. 3B. Ch1/G3 also induce light adhesiond. B) Animal in group Ch3/G1, cecumwith adhesion bond and residual pieces of ﬁlm can
Fig. 2. Quantitative analysis of adhesion. A) Number of ﬁbroblast cells around cecum can be seen in all groups. Samples in Ch1/G3 group have lowest ﬁbroblast cells number
compare to other treatment groups (P < 0.05) but compare to control group difference was insigniﬁcant (P ¼ 0.17). B) Adhesion area around one cm of cecum can be seen in all
groups. Samples with more content of chitosan have higher ﬁbrous area. All values are mean  SEM.
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ﬁbrous layers observed around a residual piece of Ch3/G1ﬁlm. In
addition, a compact of connective tissues, numerous leukocytes,
blood vessels and anchoring ﬁbroblast cells are observed in this
Figure.
4. Discussion
Chitosanegelatin ﬁlm had a number of physicochemical prop-
erties that are desirable for preventing post-operative adhesions. It
was also conﬁrmed by good handling properties during surgery but
biological assessment was surprisingly quite different. None of the
chitosanegelatin ﬁlms prevented adhesions formation and three of
them actually seemed to promote adhesion formation. This result
obscures the effects of these combinations on prevent of post-
operative adhesions. These ﬁndings are in conﬂict with earlier
studies that reported effective usage of chitosan on abdominal
adhesion reduction.
Zhou et al.24 prepared gelatinized chitosan ﬁlm without
reporting preparation method and showed the preventive effect of
ﬁlm on peritoneal adhesions induced by wound, ischemia and
infection. They reported chitosan prevents peritoneal adhesion by
the mechanisms of inhibiting growth of ﬁbroblasts, facilitating
reparation of the epithelium, and disinfection. These results
contradict our ﬁndings that reported inﬂammatory response and
tough ﬁbrous layer surrounded residual ﬁlms that induce more
adhesion bonds in samples with more than 25% weight of chitosan
after 4 weeks.
Chitosan and gelatin are derived from natural polymers and
have many properties that make them attractive for a wide variety
of biomedical applications. When they are mixed together, they
form polyelectrolytic complexes in different gelated states
depending on their concentrations. These complexes areTable 3
Pathologic assessment of adhesion.
Tests Control Ch Ch3/G1 Ch1/G1 Ch1/G3
Number of
animals
5 6 6 5 6
Fibrosis Score
(Mean  SEM)




0.4  0.25 1.67  0.33 1.5  0.43 1.4  0.25 0.33  0.21b
a Signiﬁcantly different from Ch1/G3 and Ch3/G1 groups in the ﬁbrosis score
(P ¼ 0.027).
b Signiﬁcantly different from Ch1/G3 and Ch groups in the inﬂammation score
(P ¼ 0.035).biodegradable. This degradation involves chitosan degradation and
gelatin dissolution. However, the ﬁlms with more content of chi-
tosan have slower degradation rates because of decrease in reagent
groups but it is possible to control the degradation rate by varying
the gel formulation.
The abdominal adhesion develops only several hours after the
abdominal surgical operations. At ﬁrst, the serous ﬂuid exudes from
the injured sides of intestinal wall, and then ﬁbrinogen in the se-
rous ﬂuid transforms to ﬁbrin and coagulates; thereby membra-
nous peritoneal adhesion in the injured intestinal wall is formed.
Fibrinolytic system is activated and the ﬁbrin is absorbed, thereby
the membranous peritoneal adhesion is gradually eliminated. If the
ﬁbrin cannot be totally absorbed the left ﬁbrin will be organized
and develop ﬁbrinous adhesion. Critical period for formation of
postoperative adhesion is 3e5 days after surgery. During this post-
surgical period, the ﬁbrin layer is reduced through ﬁbrinolysis and
the peritoneal membrane either becomes fully re-epithelialised or
not. If ﬁbrinolysis does not occur, an irreversible tissue bridge
(adhesion) develops and blood vessels and nerve ﬁbers may be
formwithin the following weeks and months. Therefore, candidate
ﬁlms expected not to be degraded completely in this period. Zhou
et al. also mentioned that chitosan could only prevent adhesion
during pre-ﬁbrinous stage.24 As a result, the optimal duration of the
ﬁlms to stay in the abdominal cavity is within 2 weeks and samples
that remained in abdominal cavity after 2 weeks (Chitosan, Ch3/G1,
Ch1/G1) not only are useless in prevention of adhesion but also
induce more inﬂammatory response because of inducing foreign
body reactions. In fact, if the postsurgical initial membranous ad-
hesions cannot be degraded in time, it will form irreversible ﬁbri-
nous adhesions which cannot be inhibited by chitosan. On the
contrary, the intra-abdominal residual of undegraded chitosan ﬁlm
can produce a foreign body reaction and result in the ﬁbrous
capsule formation, which facilitates the formation of abdominal
adhesion.
These were proved in our study: the adhesion grade in groups
with more concentration of chitosan (Ch, Ch3/G1, Ch1/G1) was
higher than samples in control group, and histopathologic exami-
nation indicated obvious foreign body giant cell reaction at 28 days
after surgery. These results agree with reported research of Zhang
et al.26 that investigated preventive effects of chitosan on peritoneal
adhesion in rats and concluded exacerbating effect of using chito-
san in peritoneal adhesion. Kohane and Yeo also reported an un-
expected result of using UV-cross-linked chitosan formulation. In
their study, rabbits treated with the UV-cross-linked formulation
developed exuberant adhesions, even in the absence of prior
peritoneal injury. They found that the modiﬁed chitosan and the
cross-linked gel increased the expression of proinﬂammatory cy-
tokines or chemokines such as TNF-a and MIP-2 (a murine IL-8
Fig. 3. Microscopic view of cecum. A) Normal cecum. B) Control group, medium adhesion bond can be seen around cecum. C) Ch1/G3 group, light adhesion bond can be seen. D)
Ch3/G1 group, severe adhesion bond, residual pieces of chitosan and thick ﬁbrous tissue surround ﬁlms can be seen (H&E  40).
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reason, gelatin is a polypeptide mixture, which is probably anti-
genic and can cause immunological rejection. This in turn promotes
and facilitates the formation of local peritoneal adhesions in Ch1/
G3 group and the result was not ideal for using as adhesion barrier.
One of our work limitations in blindly grading adhesion was evi-
dence of residual ﬁlms in tissue on reoperation day.
In conclusion, our results suggest that administration of chito-
sanegelatin ﬁlms with high concentration of gelatin (Ch1/G3) had
no signiﬁcant abdominal adhesion preventive effect compared to
control and also ﬁlms with more than 25% weight of chitosan not
only had no effect on reduction of adhesion formation in rat cecum
model but also increased inﬂammatory response and inducedmore
adhesions.
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